| Page 71 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.
  1. Home

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

Author(s): 
Prata PH, Eikema DJ, Afansyev B, Bosman P, Smiers F, Diez-Martin JL, Arrais-Rodrigues C, Koc Y, Poiré X, Sirvent A, Kröger N, Porta F, Holter W, Bloor A, Jubert C, Ganser A, Tanase A, Ménard AL, Pioltelli P, Pérez-Simón JA
Primary Author: 
Prata PH
Journal Title: 
Bone Marrow Transplantation
Original Publication Date: 
Dec 2019

In the absence of an HLA-matched donor, the best treatment for acquired

Bone Marrow Disease(s): 

Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study

Author(s): 
Franke GN, Kubasch AS, Platzbecker U
Primary Author: 
Franke GN
Journal Title: 
JAMA Oncology
Original Publication Date: 
Dec 2019
Bone Marrow Disease(s): 

Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis

Author(s): 
Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Braunschweig I, Budhathoki A, Shah UA, Verma AK, Murthy SB, Shastri A
Primary Author: 
Adrianzen Herrera D
Journal Title: 
Leukemia
Original Publication Date: 
Dec 2019
Bone Marrow Disease(s): 

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Author(s): 
Fenaux P, Platzbecker U, Mufti GJ, Garcia-Manero G, Buckstein R, Santini V, Díez-Campelo M, Finelli C, Cazzola M, Ilhan O, Sekeres MA, Falantes JF, Arrizabalaga B, Salvi F, Giai V, Vyas P, Bowen D, Selleslag D, DeZern AE, Jurcic JG, Germing U
Primary Author: 
Fenaux P
Journal Title: 
The New England Journal of Medicine
Original Publication Date: 
Jan 2020

BACKGROUND:

Bone Marrow Disease(s):